Use of anti-connexin polypeptide agent in combination with anti-connexin polynucleotide agent for the treatment of fibrotic conditions

Details for Australian Patent Application No. 2008343756 (hide)

Owner CoDa Therapeutics, Inc.

Inventors Duft, Bradford J.

Agent Spruson & Ferguson

Pub. Number AU-A-2008343756

PCT Pub. Number WO2009/085275

Priority 61/008,886 21.12.07 US

Filing date 22 December 2008

Wipo publication date 9 July 2009

International Classifications

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61L 24/00 (2006.01) Surgical adhesives or cements

A61P 17/02 (2006.01) Drugs for dermatological disorders

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

Event Publications

12 August 2010 PCT application entered the National Phase

  PCT publication WO2009/085275 Priority application(s): WO2009/085275

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008343758-Use of anti-connexin 43 polynucleotides for the treatment of abnormal or excessive scars

2008343755-Use of anti-connexin polynucleotides and peptides for the treatment ofabnormal or excessive scars